Catalyst Wire Dossier Catalyst Wire Dossier

2-chlorodeoxyadenosine

2-chlorodeoxyadenosine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2-chlorodeoxyadenosine, covering 2023-03-16 to 2023-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation [Phase 2]

See pricing